BIOCRYST PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $-1.1M | $21.2M |
| FY2014 | — | $75.6M | $54.5M |
| FY2015 | — | $47.7M | $28.9M |
| FY2016 | $23.0M | $1.6M | $22.1M |
| FY2017 | $23.0M | $83.8M | $50.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $-1.1M | $21.2M |
| FY2014 | — | $75.6M | $54.5M |
| FY2015 | — | $47.7M | $28.9M |
| FY2016 | $23.0M | $1.6M | $22.1M |
| FY2017 | $23.0M | $83.8M | $50.3M |